FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3957611000001104: Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26644301000001111 Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
111547301000001118 Hytrin 5mg tablets (Advanz Pharma) 7 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Is a Terazosin 5mg tablets 7 tablet true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Is pack of Hytrin 5mg tablets (Abbott Laboratories Ltd) false Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has active ingredient Terazosin hydrochloride false Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has AMP Hytrin 5mg tablets (Abbott Laboratories Ltd) true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has specific active ingredient Terazosin hydrochloride true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Hytrin 5mg tablets (Abbott Laboratories Ltd) 7 tablet Has basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start